Report
Arnaud Despre ...
  • Clément Bassat
  • Jeremy Sallee
  • Maxence Dhoury
  • Mohamed Kaabouni

La Matinale - 24-05-2023 - Portzamparc

BIOSENIC : Les cellules ALLOB prochainement disponibles pour les CRO / Contact – Acheter (1), obj. 0.52€ Cours: 0.12€ au 23/05/23
CHARGEURS : T1 en ligne, scénario 2023 confirmé / Contact – Acheter (1), obj. 24.5€ Cours: 14.4€ au 23/05/23
COMPAGNIE DES ALPES : Absorbera mieux l’inflation au S2 / Contact – Acheter (1), obj. 21.0€ Cours: 14.7€ au 23/05/23
DONTNOD : Un DLC pour Gerda – Acheter (1), obj. 13.4€ Cours: 8.64€ au 23/05/23
GENFIT : Validation de la technologie de NIS2+ dans la littérature – Acheter(1) , obj. 7.90€ Cours: 3.84€ au 23/05/23
Underlyings
Bone Therapeutics SA

Bone Therapeutics is a biotechnology company with an advanced clinical pipeline of cell products for orthopaedic conditions and bone diseases (two Phase II/III and three Phase I/II clinical studies). These areas are characterized by high unmet medical needs due to the lack of efficacious and safe, non-invasive, treatments. Co. has two products in clinical trials, its allogeneic bone cell therapy product, ALLOB®, and its autologous bone cell therapy product, PREOB®. Co. is also conducting preclinical research on next generation products, such as combined cell-matrix products for large bone defects and maxillofacial.

Chargeurs SA

Chargeurs SA is a France-based company, which provides customizable specialty material solutions. The Company and its subsidiaries operate in four sectors: Protective Films, Fashion Technologies, Museum Solutions and Luxury Materials. Protective Films designs, produces and markets technical solutions to protect the quality of steel, aluminum, plastic or other surfaces during the transformation process, as well as film application machines. Fashion Technologies produces and markets linings for clothing. Museum Solutions includes the industrial divisions Senfa, specialized in the functionalization of technical textiles, and Chargeurs Creative Collection, specialized in the provision of services to cultural institutions. Luxury Materials manufactures and markets combed wool ribbons. The Company is active globally.

Compagnie des Alpes SA

Compagnie des Alpes SA is a France-based holding company active in the tourism and leisure industry in two distinct areas: the operation and maintenance of ski resorts and the operation of family leisure parks and attractions. It equips, maintains and operates ski resorts in the Alps region in France, Italy and Switzerland. Its activities include lift handling, trail maintenance, grooming and snowmaking, and operation of ticket booths. Compagnie des Alpes SA is active in the leisure park industry through its subsidiary, Grevin & Cie SA, which manages leisure sites in France, the Netherlands, Germany, Belgium, Switzerland and the United Kingdom. It offers three types of activities: theme parks, nature and animal parks, and tourist attractions. It operates in France, Switzerland, Germany, Belgium, Russia and Luxembourg. In April 2014, it sold 30% stake in Groupe Looping to HIG Capital France, and announced the agreement with MacEarth and the aquisition of 2.5% stake in the company.

Don't Nod Entertainment SA

Dont Nod Entertainment SA. Dont Nod Entertainment SARL is a France-based video game developer. The Company develops video games for consoles and personal computers (PC) based on original concepts and technologies. The Company specializes in narrative games in a number of genres, including adventure, action and role play. Its games are natively multi-screens (consoles, PCs, Smartphone, tablets, Mac and TV). Its game portfolio includes Remember me, which includes digitized personal and intimate memories; Life is Strange, which narrates the story of Max, a photography student who suddenly discovers an internal power to go back in time, and Vampyr, which depicts London in the early 20th century after it has been ravaged by the Spanish Flu.

Genfit SA

Genfit is a biopharmaceutical company engaged in the discovery and development of drugs and biomarkers in therapeutic areas of high unmet need due to the lack of effective treatments or diagnostic tools and/or due to the increasing number of patients worldwide. Co. concentrates its research and development efforts to participate in the commercialization of treatment solutions and diagnostic tools to fight certain metabolic, inflammatory, autoimmune or fibrotic diseases affecting especially the liver (such as non-alcoholic steatohepatitis or "NASH").

Provider
Portzamparc Sponsored
Portzamparc Sponsored

​Portzamparc is a subsidary of BNP Paribas which adapted the mission to contribute to responsible and sustainable growth of private clients, management companies and SMEs . They offer personalized support adapted to the objectives in particular for Small and Medium-Sized Enterprises.

Analysts
Arnaud Despre

Clément Bassat

Jeremy Sallee

Maxence Dhoury

Mohamed Kaabouni

Other Reports on these Companies
Other Reports from Portzamparc Sponsored

ResearchPool Subscriptions

Get the most out of your insights

Get in touch